Common Contracts

18 similar Securities Agreement contracts by NovaBay Pharmaceuticals, Inc., Acelrx Pharmaceuticals Inc, Adomani, Inc., others

COMMON STOCK PURCHASE WARRANT UNUSUAL MACHINES, INC.
Securities Agreement • October 30th, 2024 • Unusual Machines, Inc. • Radio & tv broadcasting & communications equipment

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received,[*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 30, 2025 (the “Exercise Date”) and on or prior to 5:00 p.m. (New York, New York time) on April 30, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Unusual Machines, Inc., a Nevada corporation (the “Company”), up to [*] shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

AutoNDA by SimpleDocs
SERIES K COMMON STOCK PURCHASE WARRANT CATHETER PRECISION, INC.
Securities Agreement • October 25th, 2024 • Catheter Precision, Inc. • Surgical & medical instruments & apparatus • New York

THIS SERIES K COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [HOLDER] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date, as defined below (the “Initial Exercise Date”) and on or prior to the Termination Date (as defined in Section 1 below) but not thereafter, to subscribe for and purchase from Catheter Precision, Inc., a Delaware corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

AMENDED CLASS A COMMON STOCK PURCHASE WARRANT SOLUNA HOLDINGS, INC. (F/K/A MECHANICAL TECHNOLOGY, INCORPORATED)
Securities Agreement • May 15th, 2024 • Soluna Holdings, Inc • Finance services

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time following the approval of the transactions contemplated by the Fourth Amendment Agreement dated as of February 24, 2024 between and among Soluna Holdings, Inc. (formerly known as Mechanical Technology, Incorporated), a Nevada corporation (the “Company”) and the Purchasers named on Schedule A thereto (the “Amended Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 11, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from, up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

NOVABAY PHARMACEUTICALS, INC. SERIES C COMMON STOCK PURCHASE WARRANT
Securities Agreement • December 21st, 2023 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS SERIES C COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined in the letter agreement, dated December 21, 2023, between the Holder and the Company (the “Letter Agreement”)) (the “Initial Exercise Date”), and (b) on or prior to 5:00 p.m. (New York City time) on June 21, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [●] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PLACEMENT AGENT SERIES B COMMON STOCK PURCHASE WARRANT ACELRX PHARMACEUTICALS, INC.
Securities Agreement • July 21st, 2023 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations

THIS PLACEMENT AGENT SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 20, 2028 (the “Termination Date”), which Termination Date shall, upon the public announcement by the Company of the occurrence of the Series B Milestone Event, be accelerated to the date that is 45 days following the date of such public announcement, but not thereafter, to subscribe for and purchase from AcelRx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Sec

NOVABAY PHARMACEUTICALS, INC. SERIES B-1 COMMON STOCK PURCHASE WARRANT
Securities Agreement • April 27th, 2023 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS SERIES B-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date Stockholder Approval is received and effective (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES A COMMON STOCK PURCHASE WARRANT NEUROBO PHARMACEUTICALS, INC.
Securities Agreement • November 8th, 2022 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Dong-A ST Co., Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after Initial Exercise Date (as defined below) and on or prior to 5:00 p.m. (New York City time) on the first anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 5,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT RICEBRAN TECHNOLOGIES
Securities Agreement • October 20th, 2022 • RiceBran Technologies • Grain mill products

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 20, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 18, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from RiceBran Technologies, a California corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of September 14, 2022.

COMMON STOCK PURCHASE WARRANT NOVABAY PHARMACEUTICALS, INC.
Securities Agreement • September 13th, 2022 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time (x) on or after the later of (i) the six (6) month anniversary of September 9, 2022 and (ii) the Stockholder Approval Date (as defined in the Reprice Letter Agreement, dated September 9, 2022, between the Holder and the Company, as defined below (the “Reprice Letter”)) (the latter of such dates being herein after referred to as the “Initial Exercise Date”) and (y) on or prior to 5:00 p.m. (New York City time) on September 11, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this

NOVABAY PHARMACEUTICALS, INC. AMENDED COMMON STOCK PURCHASE WARRANT
Securities Agreement • September 13th, 2022 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time (x) on or after the later of (i) the six (6) month anniversary of September 9, 2022 and (ii) the Stockholder Approval Date (as defined in the Reprice Letter Agreement, dated September 9, 2022, between the Holder and the Company, as defined below (the “Reprice Letter”)) (the latter of such dates being herein after referred to as the “Initial Exercise Date”) and (y) on or prior to 5:00 p.m. (New York City time) on September 11, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this

AMENDED COMMON STOCK PURCHASE WARRANT NOVABAY PHARMACEUTICALS, INC.
Securities Agreement • September 13th, 2022 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time (x) on or after the later of (i) the six (6) month anniversary of September 9, 2022 and (ii) the Stockholder Approval Date (as defined in the Reprice Letter Agreement, dated September 9, 2022, between the Holder and the Company, as defined below (the “Reprice Letter”)) (the latter of such dates being herein after referred to as the “Initial Exercise Date”) and (y) on or prior to 5:00 p.m. (New York City time) on January 23, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this W

COMMON STOCK PURCHASE WARRANT Glimpse Group, Inc.
Securities Agreement • November 3rd, 2021 • Glimpse Group, Inc. • Services-computer programming services

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 2[9], 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Glimpse Group, Inc., a Nevada corporation (the “Company”), up to [_____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES A]1[SERIES B]2COMMON STOCK PURCHASE WARRANT ADOMANI, INC.
Securities Agreement • December 28th, 2020 • Adomani, Inc. • Motor vehicle parts & accessories

THIS [SERIES A]4[SERIES B]5 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [ ]6 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ADOMANI, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

FORM OF PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT INVIVO THERAPEUTICS HOLDINGS CORP.
Securities Agreement • April 16th, 2020 • Invivo Therapeutics Holdings Corp. • Surgical & medical instruments & apparatus • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 15, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InVivo Therapeutics Holdings Corp., a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company pursuant to the Engagement Agreement, dated as of April 14, 2020, between the Company and H.C. Wainwright & Co., LLC.

SERIES F COMMON STOCK PURCHASE WARRANT RESHAPE LIFESCIENCES INC.
Securities Agreement • September 30th, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus

THIS SERIES F COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

CLASS B COMMON STOCK PURCHASE WARRANT PROTAGONIST THERAPEUTICS, INC.
Securities Agreement • August 7th, 2018 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • Delaware

THIS CLASS B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August , 2018 (the “Initial Exercise Date”) and on or prior to the Termination Date but not thereafter, to subscribe for and purchase from Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder), the “Warrant Shares”) of the Company’s common stock, par value $0.00001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION
Securities Agreement • February 13th, 2015 • CombiMatrix Corp • Laboratory analytical instruments

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August , 2015(1) (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from CombiMatrix Corporation, a Delaware corporation (the “Company”), up to shares (as subject to adjustment and certain limitations hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). Pursuant to Rule 144, the holding period of this Warrant and the Warrant Shares issuable upon exercise hereof shall tack back to February , 2015.

COMMON STOCK PURCHASE WARRANT NEOSTEM, INC.
Securities Agreement • June 28th, 2010 • NeoStem, Inc. • Services-misc health & allied services, nec

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on May 10, 2015 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Neostem, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to (i) Section 1 of the Engagement Agreement, dated June 24, 2010, by and between the Company and Rodman & Renshaw, LLC and (ii) Section 4(2) of the Securities Act and Rule 506 promulgated thereun

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!